ArticleData in brief2024
Dataset for identifying paracentral acute middle maculopathy lesions in spectral-domain optical coherence tomography images.
Article in Data in brief, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper introduces a comprehensive dataset of spectral-domain optical coherence tomography (SD-OCT) images of human eyes affected by paracentral acute middle maculopathy (PAMM). Acquired with an SD-OCT device (Optovue, Fremont, California, USA), the dataset includes 133 OCT images of lesions. Each image is paired with a corresponding YOLO label in TXT format, representing manually annotated lesion regions of PAMM, created with the assistance of ophthalmologists. This dataset is invaluable for developing and evaluating automatic algorithms for diagnosing PAMM lesions. By providing detailed annotations and high-quality images, it facilitates advancements in understanding the morphology, progression, and potential treatments of PAMM. Furthermore, it supports the improvement of diagnostic accuracy and the development of targeted therapeutic interventions for retinal diseases. This resource addresses a significant gap in the availability of public datasets focused on PAMM lesions, promoting further research in automated intelligent analysis systems for retinal OCT images.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.